This study is currently recruiting.

Description: A Randomized, Double-blind, Placebo-controlled, Parallel Group Study ofBPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome.

Eligibility & Criteria

IRB #: IRB00353081

Principal Investigator: Dejan B. Budimirovic, MD

Eligible Age Range:  18 to 45 years

Gender: Male Only

Diagnosis: Fragile X Syndrome